Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 18-27

  Melby, Peter C ^a,b   Yang, Yan Zhu ^a   Cheng, Jun ^a   Zhao, Weiguo ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HEPATOSPLENOMEGALY; INOCULATION; INTERFERON PRODUCTION; LEISHMANIA DONOVANI; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SPLEEN CELL; VISCERAL LEISHMANIASIS;

EID: 0031985666     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.18-27.1998     Document Type: Article

References (45)

1. Alard, P., O. Lantz, M. Scbagh, C. F. Calvo, D. Weill, G. Chavanel, A. Senik, and B. Charpentier. 1993. A versatile ELISA-PCR assay for mRNA quantitation from a few cells. BioTechniques 15:730-737.
2. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Nail. Acad. Sci. USA 84:6020-6024.
3. Badaro, R., T. C. Jones, E. M. Canalho, D. Sampaio, S. G. Reed, A. Barral, R. Teixeira, and VV. D. Johnson. 1986. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1003-1011.
4. Barral-Nctto, M., A. Barrai, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
5. Bogdan, C., Y. Vodovotz, J. Paik, Q.-W. Xie, and C. Nathan. 1994. Mechanism of suppression of nitric oxide synthase expression by interleukin 4 in primary mouse macrophages. J. Leukocyte Biol. 55:227-233.
6. Buffet, P. A., A. Sulahian, Y. J. F. Garin, N. Nassar, and F. Derouin. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infanlum in tissues of infected mice. Antimicrob. Agents Chemother. 39:2167-2168.
7. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotcs selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
8. Can-alho, E. M., R. Badaro, S. G. Reed, T. C. Jones, and W. D. Johnson. 1985. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:2066-2069.
9. Canalho, E. M., R. S. Teixeira, and W. D. Johnson. 1981. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosupprcssion during acute infection. Infect. Immun. 33:498-502.
10. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Guidizi, R. Biagiotti, and S. Romangnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360.
11. Ding, A., C. F. Nathan, J. Grajcar, R. Derynck, D. J. Stuehr, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145:940-944.
12. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148:1792-1796.
13. Gessner, A., M. Vieth, A. Will, K. Schroppel, and M. Rollinghoff. 1993. Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages. Infect. Immun. 61:4008-4012.
14. Green, S. J., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
15. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for the expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
16. Heinzel, F. P., M. D. Sadick, S. S. Mutha, and R. M. Locksley. 1991. Production of interferon-γ, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
17. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
18. Karp, C. L., S. H. EI-Safi, T. A. Wynn, M. M. H. Satti, A. M. Korofani, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In mo cytokine profiles in patients with Kala-azar: marked elevation of both IL-10 and IFN-gamma. J. Clin. Invest. 91:1644-1648.
19. Kaye, P. M., A. J. Curry, and J. M. Blackuell. 1991. Differential production of Th1- and Th2 derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:2763-2770.
20. Kirkpatrick, C. E., T. J. Nolan, and J. P. Farrell. 1987. Rate of Leishmaniainduccd skin-lesion development in rodents depends on the site of inoculation. Parasitology 32:451-465.
21. Laskay, T., A. Diefenbach, M. Rollinghoff, and W. Solbach. 1995. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25:2220-2227.
22. Macatonia, S. E., N. A. Hoskcn, M. Litton, P. Viera, C.-S. Hsieh, J. A. Culpepper, M. Wysocka, G. Trinchieri, K. M. Murphy, and A. O'Garra. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cell from naive CD4+ T cells. J. Immunol. 154:5071-5079.
23. MacElrath, M. J., H. W. Murray, and Z. A. Cohn. 1988. The dynamics of granuloma formation in experimental visceral leishmaniasis. J. Exp. Med. 167:1927-1937.
24. 23a.Melby, P. C. Unpublished data.
25. Melby, P. C., F. A. Neva, and D. L. Sacks. 1989. Profile of human T cell response to leishmanial antigens: analysis by immunoblotting. J. Clin. Invest. 83:1868-1875.
26. Melby, P. C., F. J. Andrade-Narvaez, B. J. Darnell, G. Valencia-Pacheco, V. V. Trjon, and A. Palomo-Cetina. 1994. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect. Immun. 62:837-542.
27. Melby, P. C., F. J. Andrade-Narvaez, B. J. Darnell, and G. Valencia-Pacheco. 1996. In situ expression of IL-10 and IL-12 in human cutaneous leishmaniasis. FEMS Immunol. Med. Microbiol. 15:101-107.
28. Melby, P. C., G. Valencia-Pacheco, and F. Andrade-Navaez. 1996. Induction of macrophage killing of intracellular Leishmania donmani by human T cell clones. Arch. Med. Res. 27:473-479.
29. 27a.Melby, P. C., et al. Unpublished data.
30. Miralles, G. D., M. Y. Stoeckle, D. F. McDermott, F. D. Finkelman, and H. W. Murray. 1994. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1058-1063.
31. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387-391.
32. Murray, H. W., H. Masur, and J. S. Keithly. 1982. Cell mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J. Immunol. 129:344-350.
33. Nabors, G. S., T. Nolan, W. Croop, J. Li, and J. P. Farrell. 1995. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in BALB/c × C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol. 17:569-579.
34. Pampiglione, S., P. E. C. Manson-Bahr, F. Giungi, G. Giunti, A. Parenti, and G. Canestri Trotti. 1974. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 68:447-453.
35. Scharton-Kerston, T., I., C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
36. Southgate, B. A., and P. E. C. Manson-Bahr. 1967. Studies on the epidemiology of East African leishmaniasis. 4. The significance of the positive leishmanin test. J. Trop. Med. Hyg. 70:29-33.
37. Squires, K. E., R. D. Schreiber, M. J. McElrath, B. Y. Rubin, S. L. Anderson, and H. W. Murray. 1989. Experimental visceral leishmaniasis: role of endogenous IFN-γ in host defense and tissue granulomations response. J. Immunol. 143:4244-4249.
38. Steinman, R. M. 1991. The dendritic cell system and ils role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
39. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
40. Stern, J. J., M. J. Oca, B. Y. Rubin, S. L. Anderson, and H. W. Murray. 1988. Role of L3T4+ and LYT-2+ cells in experimental visceral leishmaniasis. J. Immunol. 140:3971-3977.
41. Theodos, C. M., L. Povinelli, R. Molina, B. Sherry, and R. Titus. 1991. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59:2839-2842.
42. H1 cells. Immunol. Today 14:335-337.
43. Tumang, M. C. T., C. Keogh, L. L. Moldauer, D. C. Helfgott, R. Teitelbaum, J. Hariprashad, and H. W. Murray. 1994. Role and effect of TNF-α in experimental visceral leishmaniasis. J. Immunol. 153:768-775.
44. Vieth, M., A. Will, K. Schroppd, M. Rollinghoff, and A. Gessner. 1994. Interleukin 10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40:403-409.
45. Wilson, M. E., M. Sandor, A. M. Blum, B. M. Young, A. Metwali, D. Elliott, R. G. Lynch, and J. V. Weinstock. 1996. Local suppression of IFN-γ in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156:2231-2239.